Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Withdrawn 2Terminated 1Completed 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 16Neoplasm Metastasis 4Breast Neoplasms 2Triple Negative Breast Neoplasms 1Granulosa Cell Tumor 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × orteronel × Clear all
NCT02101684 2018-03-05

Greko II

Grupo EspaƱol de Tumores HuƩrfanos e Infrecuentes

Phase 2 Terminated
10 enrolled

Granulosa Cell Tumor, Neoplasm Metastasis

NCT01658527 2016-06-10

TAK-700 in Castration Resistant Prostate Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00569153 2016-04-04

TAK-700

Millennium Pharmaceuticals, Inc.

Phase 1/2 Completed
123 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02054793 2014-07-23

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

Johns Hopkins University

Phase 1/2 Withdrawn
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔